Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chemicals is a biotechnology company that leverages artificial intelligence and machine learning to accelerate the discovery and development of novel small molecule therapeutics. The company's proprietary platform, Chemicals.ai, integrates high-throughput screening data with advanced computational models to predict molecular properties and optimize lead candidates. By streamlining the early-stage drug discovery process, Chemicals aims to reduce the time and cost associated with bringing new treatments to market. The company focuses on identifying high-affinity ligands for challenging biological targets across various therapeutic areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chemicals.